ARKG vs. HDRO ETF Comparison
Comparison of ARK Genomic Revolution Multi-Sector ETF (ARKG) to Defiance Next Gen H2 ETF (HDRO)
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.
Grade (RS Rating)
Last Trade
$24.84
Average Daily Volume
2,032,532
33
HDRO
Defiance Next Gen H2 ETF
HDRO Description
ETF Series Solutions - Defiance Next Gen H2 ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Defiance ETFs, LLC and Penserra Capital Management, LLC. It invests in the public equity markets of global region. The fund invests in stocks of companies operating across materials, chemicals, industrial gases, utilities, alternative energy resources, fuel cells, independent power and renewable electricity producers, renewable electricity, development of hydrogen-based energy source sectors. It invests in growth and value stocks of companies operating across diversified market capitalization. The fund seeks to track the performance of the BlueStar Global Hydrogen & NextGen Fuel Cell Index, by using full replication technique. ETF Series Solutions - Defiance Next Gen H2 ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$4.69
Average Daily Volume
24,605
5
Performance
| Period | ARKG | HDRO |
|---|---|---|
| 30 Days | -5.87% | 0.64% |
| 60 Days | 0.89% | -2.49% |
| 90 Days | 7.25% | -7.68% |
| 12 Months | -6.23% | -24.15% |
0 Overlapping Holdings
| Symbol | Grade | Weight in ARKG | Weight in HDRO | Overlap |
|---|
ARKG Overweight 33 Positions Relative to HDRO
| Symbol | Grade | Weight | |
|---|---|---|---|
| TWST | D | 8.85% | |
| RXRX | F | 6.86% | |
| CDNA | B | 6.66% | |
| CRSP | F | 6.16% | |
| NTLA | F | 4.76% | |
| VCYT | C | 4.34% | |
| IONS | F | 4.26% | |
| ADPT | B | 4.25% | |
| TXG | F | 4.22% | |
| NRIX | D | 3.85% | |
| BEAM | F | 3.67% | |
| NTRA | A | 3.48% | |
| ARCT | D | 3.42% | |
| SDGR | F | 3.31% | |
| PSNL | D | 2.74% | |
| GH | F | 2.57% | |
| VEEV | C | 2.12% | |
| ABSI | F | 1.95% | |
| MRNA | F | 1.85% | |
| AMGN | D | 1.83% | |
| VRTX | D | 1.77% | |
| PACB | F | 1.64% | |
| ACCD | F | 1.55% | |
| REGN | D | 1.18% | |
| EXAS | C | 1.15% | |
| CMPS | F | 1.04% | |
| INCY | B | 1.03% | |
| CERS | F | 1.02% | |
| BFLY | B | 1.0% | |
| MASS | F | 0.88% | |
| QSI | F | 0.8% | |
| PRME | F | 0.75% | |
| RPTX | D | 0.66% |
ARKG: Top Represented Industries & Keywords
HDRO: Top Represented Industries & Keywords
Compare ETFs
